NNVC Nanoviricides
- 2.070
- -0.160-7.17%
- 2.130
- +0.060+2.90%
Nanoviricides News
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Nanoviricides | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Nanoviricides | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Nanoviricides | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Nanoviricides | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Nanoviricides | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Nanoviricides | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Nanoviricides | 3: Initial statement of beneficial ownership of securities
Nanoviricides | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Nanoviricides | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Nanoviricides | 3: Initial statement of beneficial ownership of securities
Nanoviricides | D: Filing D
Nanoviricides | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Nanoviricides | 4: Statement of changes in beneficial ownership of securities
Analysis
Price Target
No Data
